take teva downgrad celltrion hc vulner event materi
teva potenti product delay bigger implic
celltrion hc cthc vs celltrion inc cti given schedul
us launch truxima herzuma post
anticip approv dec respect
weve yet assum delay product launch us
uncertainti rise event expect cthc would
vulner cti could hide earn behind cthc
cthc may cthc shipment schedul could
delay depend approv timelin
cthc effort revis contract term floor price etc
sale partner address earn
event reflect celltrion improv bargain power point
earn downsid still exist end-pric continu erod
reiter under-perform view earn matter
share price remain untouch despit recent miss
on-going slow top-line cycl weigh fine tune
ep align model celltrion inc
favor contract encourag sign
celltrion hc free earn downsid
cthc make effort revis contract term sale
partner teva address
earn event ceo cthc set floor price
remsima/truxima protect margin end-pric erosionif
price fall floor price region partner share
increment loss celltrion group previous deficit
mostli absorb cti cthc particularli cthc view
henc chang reflect celltrion improv bargain power
point earn downsid still exist end-pric
remsima/truxima continu erod separ herzuma
differ contract structur accord compani floor
price herzuma celltrion group would respons
end-pric cut herzuma deliv sale partner
celltrion profit preserv
figur cs assumpt celltrion group transact
estimate pot chg tp
 chang prev ep
note celltrion healthcar conduct global market sale distribut biolog product
develop celltrion inc master distributorship agreement partnership region
click detail financi
celltrion hc could vulner celltrion inc
teva potenti product delay bigger implic celltrion hc
cthc vs celltrion inc cti given schedul us launch
truxima herzuma post anticip
approv dec respect
weve yet assum delay product launch us
uncertainti rise event expect cthc would
vulner cti could hide earn behind cthc
cthc may cthc shipment schedul could delay
depend approv timelin
reiter under-perform earn matter
cthc share price remain untouch despit recent miss
normal opm would on-going slow top-line
cycl weigh despit improv non-remsima mix
top-line deliveri remain
expect fine tune ep align
model celltrion inc
remsima mix
inclus bn sale compani data credit suiss estim
seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid
report singl factor make invest decis
compani mention price
ray certifi view express report accur reflect person view subject compani secur
part compens directli indirectli relat specif recommend view express report
price rate histori celltrion healthcar co ltd
signifi initi assumpt coverag
price rate histori celltrion inc
signifi initi assumpt coverag
price rate histori pfe
signifi initi assumpt coverag
price rate histori teva pharmaceut teva
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst coverag univers
consist compani cover analyst within relev sector outperform repres attractiv neutral less attract
underperform least attract invest opportun octob canadian well european ra ting base stock total return
rel analyst coverag univers consist compani over analyst within relev sector outperform repres
attract neutral less attract underperform least attract invest opportun latin american asia stock exclud japan
australia rate base stock total return rel averag total return relev countri region benchmark india bse sensex index
prior octob canadian rate base stock absolut total return potenti current share price rel
attract stock total return potenti within analyst coverag univers australian new zealand stoc ks expect total return calcul
includ roll dividend yield outperform rate assign greater equal under-perform wh ere less
equal neutral may assign overlap rate rang allow analyst assign rate put
context associ risk prior may rang outperform under-perform rate overlap ne utral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
rate nr credit suiss equiti research invest rate view stock secur relat compani
time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate invest view
equiti secur compani relat product
volatil indic stock defin volatil stock price move month least past
month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or valuat
sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cover multipl sector
credit suiss distribut stock rate bank client
bank client
purpos nyse finra rate distribut disclosur requir stock ate outperform neutral under-perform close correspond
